DINGDANG HEALTH(09886.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
DINGDANG HEALTH
09886.HK
Dingdang Health Technology Group Ltd. provides digital healthcare services in the People’s Republic of China. The company offers online medical consultation through online and supplementary services; chronic diseases management; and health portfolio management and DOT medication adherence services. It provides a range of health products through offline retail and online direct sales channels Dingdang Health Technology Group Ltd.
357.91 B
09886.HKMarket value -Rank by Market Cap -/-

Financial Score

23/01/2026 Update
C
Drug RetailIndustry
Industry Ranking6/7
Industry medianB
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-19.09%E
    • Profit Margin-7.27%D
    • Gross Margin35.06%C
  • Growth ScoreD
    • Revenue YoY-2.91%D
    • Net Profit YoY-74.08%E
    • Total Assets YoY-1.46%D
    • Net Assets YoY-12.16%E
  • Cash ScoreD
    • Cash Flow Margin-1375.73%E
    • OCF YoY-2.91%D
  • Operating ScoreA
    • Turnover1.61A
  • Debt ScoreC
    • Gearing Ratio42.09%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Dingdang Health Repurchases 330,500 Shares for HKD 391,497 in HKEX Filing

    Dingdang Health Technology Group Ltd. has announced the repurchase of 330,500 shares for a total of HKD 391,497, as disclosed in a filing with the Hong Kong Stock Exchange. The shares are intended for cancellation.

    Reuters·
    HK
    09886
    -1.96%
    Reuters·
    HK
    09886
    -1.96%

    Morning Trend | DINGDANG HEALTH has extremely low trading volume, who dares to bet on a rebound in the differentiated structure?

    Yesterday, the digital health sector's performance was relatively flat, with DINGDANG HEALTH (9886.HK) experiencing low trading volume throughout the day, and major funds maintaining a wait-and-see attitude. The sector's hotspots are gradually shifting towards other sub-segments of digital healthcare, with no significant movements in related company announcements, and funds continue to observe. Occasionally, there were attempts to lift prices during short-term trading, but no effective breakthroughs were formed. Technical signals are trending towards neutrality, with limited market fluctuations and weak trading willingness. Overall, it is primarily a game of existing funds, with extremely low volatility and flat intraday trading performance. Without major industry news or sector linkage stimuli, DINGDANG HEALTH's short-term performance momentum is limited. Changes in intraday trading and emotional fluctuations will be key points of focus moving forward, and caution is still needed regarding heavy positions. It is recommended to test with light positions and pay attention to sector news and intraday fluctuations

    Technical Forecast·
    HK
    09886
    -1.96%
    Technical Forecast·
    HK
    09886
    -1.96%

    Dingdang Health Repurchases 99,500 Shares for HK$105,390.40 in HKEX Filing

    Dingdang Health Technology Group Ltd. has announced the repurchase of 99,500 ordinary shares for cancellation, with a total cost of HKD 105,390.4, as disclosed in a filing with the Hong Kong Stock Exchange.

    Reuters·
    HK
    09886
    -1.96%
    Reuters·
    HK
    09886
    -1.96%

    Zhitong Hong Kong Stock 52-week new high and new low statistics | October 6

    As of the close on October 6, 133 stocks in the Hong Kong stock market reached a 52-week high. BEIDA JADE BIRD, ZHONGHUA GAS, and DINGDANG HEALTH ranked the top three with high rates of 67.47%, 50.00%, and 33.01%, respectively. Other outstanding stocks include Zhongbo Data, Tianrui Automotive Interior, and K2 F&B

    Zhitong·
    HK
    08095
    +8.33%
    HK
    08246
    0.00%
    HK
    09886
    -1.96%
    Zhitong·
    HK
    08095
    +8.33%
    HK
    08246
    0.00%
    HK
    09886
    -1.96%

    Understanding the Market | DINGDANG HEALTH surged nearly 25% as the company continues to increase its investment in innovative drug layout, recently launching multiple innovative drugs

    DINGDANG HEALTH surged nearly 25% during trading, and as of the time of publication, it rose 23.71% to HKD 1.20, with a transaction volume of HKD 12.7801 million. In terms of news, DINGDANG HEALTH continues to increase its investment in innovative drug layouts. Recently, DINGDANG HEALTH's pharmacy has launched the anti-tumor Class 1 innovative drug, hydrochloride lauroxil tablets, and has completed its first order service. Notably, DINGDANG HEALTH recently reached a cooperation agreement with Xiansheng Pharmaceutical, where Xiansheng Pharmaceutical's insomnia drug, daridorexant, made its O2O debut at DINGDANG HEALTH. Additionally, in early September, the company collaborated with Eli Lilly to launch teriparatide injection in pharmacies in Guangzhou and Shenzhen; in July, it partnered with Novo Nordisk to launch the weight management version of semaglutide. It is reported that since February of this year, DINGDANG HEALTH has cooperated with dozens of original drug companies to launch the "Original Drug Supply Guarantee Alliance."

    Zhitong·
    HK
    09886
    -1.96%
    Zhitong·
    HK
    09886
    -1.96%
    © 2026 Longbridge｜Disclaimer